Brian Brothen Email & Phone Number

Palm Coast, Fl, Us

San Carlos, California, Us

• Provided executive sales leadership for an innovative 3-D ultrasound for breasts imaging for a startup company.• Directed multi-faceted marketing and sales strategies to increase brand awareness and drive international sales.• Contracted with a marketing expert to develop a “blue ocean strategy” charting out a winning commercial strategy.• Aligned strategies by garnering key opinions from commercial and government payors and the reimbursement community.• Assembled advisory boards to obtain expert medical guidance and recommendations on product placement.• Employed relationship based and consultative approaches in understanding physician perspectives and needs.• Led cross-functional team efforts including Marketing and Reimbursement to drive market share• Negotiated and implemented favorable contract terms with clients for capital equipment ultrasound purchases.• Lead commercial and business development efforts.• Collaborated with AI, genetic, and genomic company partners for successful product deployment.• Key Accomplishments:- Developed successful a go to market (GTM) strategy by strategically realigning marketing efforts resulting in growing from zero product sales to an initial order for 11 scanners across the United States and Europe.- Planned and implemented a clinical study utilizing a newly assembled medical advisory board.

• Founded and led a startup genomics company promoting novel Next Generation Sequencing (NGS) genomic assays. • Directed the development and implementation of the product portfolio’s commercialization strategy. • Evaluated, built, and managed multi-channel marketing initiatives to deliver on the company’s growth objectives. • Cultivated relationships with Key Opinion Leaders (KOL), thought leaders, and patient advocacy organizations.• Collaborated with MDs and PhDs to implement clinical studies to evaluate effectiveness of diagnostic assays. • Solicited feedback from payers and reimbursement experts to plan for appropriate patient access for the assays.• Oversaw efforts to improve market access and established effective product pricing.• Key Accomplishment:- Planned and established clinical trials in 5 academic centers while partnering with 2 laboratory vendors.

• Led planning and execution of the commercial sales strategy for a comprehensive NGS platform PCDx Cancer Assay. • Oversaw development and deployment of successful product pre-launch and launch activities.• Managed and led National Oncology sales team.• Coached and developed team on selling strategy, account management, sales acumen, and product knowledge.• Presented clinical study findings to investors, academic center physician leaders, and key influencers.• Partnered with Key Opinion Leaders and influential physicians at the top cancer centers throughout the US.• Key Accomplishments:- Increased PCDx sales and market share month over month achieving over 528% growth in the first year.- Developed and implemented a clinical study using PCDx generating significant results within 6 months.

Seattle, Wa, Us

• Promoted and launched Prosigna (molecular profiling breast cancer assay) across the southeast region.• Called on medical oncologists, breast surgeons, molecular scientists and pathologists in large cancer centers.• Utilized the Pharmaceutical Therapeutic Selling Model to influence sales targets and drive market share.• Collaborated with key National Accounts Managers to drive sales at Mayo Clinic, Moffitt, and University of Miami.• Led national calls on sales training reviewing the competitive landscape including product positioning and POAs.• Key Accomplishment: Ranked as a top sales performer consistently throughout tenure.

Irvine, Ca, Us

• Directed sales for MammaPrint the first FDA cleared IVDMIA Gene Expression Assay for breast cancer recurrence. • Called on leading breast surgeons, pathologists, and medical oncologists at cancer centers across the east coast.• Managed key national accounts and guided and supported sales representatives with large account conversions.• Interviewed, hired, and trained new sales representatives utilizing self-created training slide decks.• Developed a Speaker’s Bureau and Advisory Board and provided product training to physicians nationally.• Trained key thought leaders on slide decks and provided presentations directly when physicians were not available.• Key Accomplishments: - Won the President’s Club Award in 2009, 2011, 2012, and 2013 for top sales achievements.- Achieved establishment of a standing order to utilize the assay automatically for specific patient types.- Ranked 1/45 and 2/45 nationally and awarded Oncology Sales Specialist of the Year in 2009 and 2010.- Exceeded retention goal with 85-90% of converted accounts versus 30% national average 2009 - 2011.- Collaborated with CMO and MSL team to develop and establish 3 clinical trials utilizing MammaPrint nationally resulting in an increase of national sales by 30% and produced clinically relevant study results.

• Launched Vidaza, the first DNA Hypomethylating agent approved by the FDA for the treatment of all types of Myleodysplastic Syndromes.Key Accomplishments:- Consistently exceeded goals and expectations for 2004, 2005, 2006, and 2007- Nationally ranked in the top 6% for overall goal obtainment from 2004 through 2008 - Ranked #1 in the South region for 2005- Promoted to Clinical Account Manager in February 2006- 2005 “Make My Day” national award winner

Paris, France, Fr

• Launched Oxaliplatin, used for the treatment of metastatic colorectal cancer.• Key accomplishments:- Consistently exceeded all sales goals- Ranked #1 sales representative in the southeast for 3 out of 5 quarters- Received the highest possible rating for the annual review

Kenilworth, New Jersey, Us

• Top 5% of sales force nationally for 1998, Fareston (Launch of New Breast Cancer Therapy)• Top 20% of sales force nationally for Rebetron, (Hepatitis C Therapy)• Ranked #2 on the Southeast Team with 97% growth over 2001• Sales growth from $200,000 per month to $1,000,000 per month